| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |